Examkin

Question

Difficulty: Very hardSleep-Wake Disorders

A 38-year-old woman comes to the clinic reporting persistent daytime fatigue and sleepiness for the past 14 months. She works as a software engineer and frequently dozes off at her desk during the mid-afternoon, occasionally making embarrassing errors in her code. She goes to bed at 10:30 PM and wakes up at 6:30 AM daily, feeling relatively refreshed initially, but severe sleepiness returns by midday. She reports that occasionally, right before drifting off to sleep at night, she hears unfamiliar voices calling her name in the room, though she lives alone. She has no episodes of sudden muscle weakness when laughing or angry. Her medical history is unremarkable, and she takes no medications. Physical examination is within normal limits. An overnight polysomnogram (PSG) reveals a total sleep time of 7.9 hours, an apnea-hypopnea index of 1.5 events/hour, and a rapid eye movement (REM) sleep latency of 10 minutes. The next day, a multiple sleep latency test (MSLT) demonstrates a mean sleep latency of 5.5 minutes and 1 sleep-onset REM period (SOREMP). Which of the following is the most appropriate next step in the management of this patient?

  1. Prescribe modafinilAnswer
  2. B
    Schedule a repeat multiple sleep latency test
  3. C
    Prescribe continuous positive airway pressure therapy
  4. D
    Prescribe pramipexole
  5. E
    Advise strict sleep hygiene and schedule a follow-up in 3 months

Answer

The correct answer is to prescribe modafinil.
The correct answer is prescribing modafinil. This patient presents with severe excessive daytime sleepiness and hypnagogic hallucinations (hearing voices when falling asleep), which are classic symptoms of narcolepsy. The definitive diagnosis of narcolepsy requires objective testing with a multiple sleep latency test (MSLT). The criteria mandate a mean sleep latency of ≤ 8 minutes and the presence of ≥ 2 sleep-onset REM periods (SOREMPs). While this patient's MSLT only demonstrated 1 SOREMP, she had a REM latency of 10 minutes on the preceding night's polysomnogram (PSG). According to standardized diagnostic criteria, a REM latency of ≤ 15 minutes on the preceding night's PSG counts as one of the required SOREMPs. Therefore, combining the 1 SOREMP from the PSG and the 1 SOREMP from the MSLT satisfies the requirement of ≥ 2 SOREMPs. Because she lacks cataplexy, she has narcolepsy type 2. Modafinil, a wakefulness-promoting agent, is a first-line pharmacotherapy for managing daytime sleepiness in narcolepsy.

Step-by-Step Solution

1
Identify the patient's primary symptoms and behavioral history.
Excessive daytime sleepiness for over 3 months despite adequate (8 hours) sleep, accompanied by hypnagogic hallucinations (hearing voices while falling asleep), raising high clinical suspicion for narcolepsy.
Establishing the clinical presentation is the first step in directing the interpretation of the objective sleep studies.
2
Evaluate the overnight polysomnogram (PSG) findings.
The apnea-hypopnea index (AHI) is 1.5 events/hour (normal is < 5), ruling out obstructive sleep apnea. The REM sleep latency is abnormally short at 10 minutes.
PSG is required to rule out other causes of hypersomnolence (like OSA) and provides crucial baseline sleep architecture data.
3
Apply the diagnostic criteria rule regarding REM latency on the PSG.
A REM sleep latency of 15 minutes or less on the preceding night's PSG qualifies as one sleep-onset REM period (SOREMP).
This is a critical, advanced nuance in the diagnostic criteria for narcolepsy that prevents false-negative interpretations of the MSLT.
4
Evaluate the multiple sleep latency test (MSLT) findings.
The mean sleep latency is severely reduced at 5.5 minutes (pathological is ≤ 8 minutes), and 1 SOREMP is observed during the daytime naps.
The MSLT provides the objective measure of daytime sleepiness and propensity to enter REM sleep quickly.
5
Synthesize the total SOREMP count and confirm the diagnosis.
1 SOREMP (from PSG) + 1 SOREMP (from MSLT) = 2 total SOREMPs. Combined with the mean sleep latency ≤ 8 minutes and absence of cataplexy, this confirms Narcolepsy Type 2.
Accurate diagnosis dictates the appropriate pharmacological intervention.
6
Determine the most appropriate first-line management.
Modafinil is selected to manage the patient's debilitating daytime sleepiness.
Modafinil, a non-amphetamine wakefulness-promoting agent, is standard first-line therapy for narcolepsy.

Key Concept

The diagnosis of narcolepsy requires an MSLT showing a mean sleep latency ≤ 8 minutes and ≥ 2 SOREMPs; crucially, a REM latency ≤ 15 minutes on the preceding night's PSG counts as one of the required SOREMPs.
Rate this question

Topics

Sleep-Wake Disorders

More questions from this topic